PTEN and PI-3 kinase inhibitors control LPS signaling and the lymphoproliferative response in the CD19+ B cell compartment

Ogata, 2000, The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells, J. Exp. Med., 192, 23, 10.1084/jem.192.1.23 Yazawa, 2003, CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes, Blood, 102, 1374, 10.1182/blood-2002-11-3573 Pasare, 2005, Control of B-cell responses by toll-like receptors, Nature, 438, 364, 10.1038/nature04267 Ha, 2006, Regulation of B1 cell migration by signals through Toll-like receptors, J. Exp. Med., 203, 2541, 10.1084/jem.20061041 Akira, 2006, Pathogen recognition and innate immunity, Cell, 124, 783, 10.1016/j.cell.2006.02.015 Guttridge, 1999, NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1, Mol. Cell. Biol., 19, 5785, 10.1128/MCB.19.8.5785 Duyao, 1990, Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter, Proc. Natl. Acad. Sci. U. S. A., 87, 4727, 10.1073/pnas.87.12.4727 Barrio, 2013, TLR4 signaling shapes B cell dynamics via MyD88-dependent pathways and Rac GTPases, J. Immunol, 191, 3867, 10.4049/jimmunol.1301623 Hwang, 2009, TLR4 signaling augments B lymphocyte migration and overcomes the restriction that limits access to germinal center dark zones, J. Exp. Med., 206, 2641, 10.1084/jem.20091982 Lee, 1999, Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association, Cell, 99, 323, 10.1016/S0092-8674(00)81663-3 Maehama, 1998, The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate, J. Biol. Chem., 273, 13375, 10.1074/jbc.273.22.13375 Gunzl, 2008, Recent advances in the genetic analysis of PTEN and PI3K innate immune properties, Immunobiology, 213, 759, 10.1016/j.imbio.2008.07.028 Stocker, 2002, Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB, Science, 295, 2088, 10.1126/science.1068094 Li, 2003, Phosphoinositide 3 kinase mediates toll-like receptor 4-induced activation of NF-kappa B in endothelial cells, Infect. Immun., 71, 4414, 10.1128/IAI.71.8.4414-4420.2003 Laird, 2009, TLR4/MyD88/PI3K interactions regulate TLR4 signaling, J. Leukoc. Biol., 85, 966, 10.1189/jlb.1208763 Ojaniemi, 2003, Phosphatidylinositol 3-kinase is involved in toll-like receptor 4-mediated cytokine expression in mouse macrophages, Eur. J. Immunol., 33, 597, 10.1002/eji.200323376 Jones, 2001, Differential roles of toll-like receptors in the elicitation of proinflammatory responses by macrophages, Ann. Rheum. Dis., 60, iii6-12 Akira, 2003, Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling, J. Infect. Dis., 187, S356, 10.1086/374749 Cao, 2004, The inositol 3-phosphatase PTEN negatively regulates Fc gamma receptor signaling, but supports toll-like receptor 4 signaling in murine peritoneal macrophages, J. Immunol., 172, 4851, 10.4049/jimmunol.172.8.4851 Kamo, 2013, PTEN-mediated Akt/beta-catenin/Foxo1 signaling regulates innate immune responses in mouse liver ischemia/reperfusion injury, Hepatology, 57, 289, 10.1002/hep.25958 Lee, 2003, Reciprocal modulation of toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids, J. Biol. Chem., 278, 37041, 10.1074/jbc.M305213200 Luyendyk, 2008, Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages, J. Immunol., 180, 4218, 10.4049/jimmunol.180.6.4218 Fruman, 1999, Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha, Science, 283, 393, 10.1126/science.283.5400.393 Suzuki, 1999, Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase, Science, 283, 390, 10.1126/science.283.5400.390 Clayton, 2002, A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation, J. Exp. Med., 196, 753, 10.1084/jem.20020805 Omori, 2006, Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling, Immunity, 25, 545, 10.1016/j.immuni.2006.08.015 Suzuki, 2003, Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination, J. Exp. Med., 197, 657, 10.1084/jem.20021101 Anzelon, 2003, Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function, Nat. Immunol., 4, 287, 10.1038/ni892 Rudelius, 2006, Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma, Blood, 108, 1668, 10.1182/blood-2006-04-015586 Uddin, 2006, Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival, Blood, 108, 4178, 10.1182/blood-2006-04-016907 Miletic, 2010, Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases, J. Exp. Med., 207, 2407, 10.1084/jem.20091962 Shen, 2006, Development of autoimmunity in IL-14alpha-transgenic mice, J. Immunol., 177, 5676, 10.4049/jimmunol.177.8.5676 Suzuki, 2003, Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination, J. Exp. Med., 197, 657, 10.1084/jem.20021101 Shen, 2006, Development of autoimmunity in IL-14{alpha}-transgenic mice, J. Immunol., 177, 5676, 10.4049/jimmunol.177.8.5676 Rickert, 1997, B lymphocyte-specific, Cre-mediated mutagenesis in mice, Nucleic Acids Res., 25, 1317, 10.1093/nar/25.6.1317 Schmittgen, 2008, Analyzing real-time PCR data by the comparative C(T) method, Nat. Protoc., 3, 1101, 10.1038/nprot.2008.73 Mahadevan, 2012, Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies, Eur. J. Cancer, 48, 3319, 10.1016/j.ejca.2012.06.027 Garlich, 2008, A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity, Cancer Res., 68, 206, 10.1158/0008-5472.CAN-07-0669 Monick, 2001, Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin, J. Immunol., 166, 4713, 10.4049/jimmunol.166.7.4713 Gustin, 2006, Akt regulates basal and induced processing of NF-kappaB2 (p100) to p52, J. Biol. Chem., 281, 16473, 10.1074/jbc.M507373200 Tergaonkar, 2006, NFkappaB pathway: a good signaling paradigm and therapeutic target, Int. J. Biochem. Cell Biol., 38, 1647, 10.1016/j.biocel.2006.03.023 Scheidereit, 2006, IkappaB kinase complexes: gateways to NF-kappaB activation and transcription, Oncogene, 25, 6685, 10.1038/sj.onc.1209934 Ambrus, 1985, Human B lymphoma cell line producing B cell growth factor, J. Clin. Invest., 75, 732, 10.1172/JCI111754 Ambrus, 1990, Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor, J. Immunol., 145, 3949, 10.4049/jimmunol.145.12.3949 Liou, 2003, Distinctions between c-Rel and other NF-kappaB proteins in immunity and disease, Bioessays, 25, 767, 10.1002/bies.10306 Karin, 2002, NF-kappaB at the crossroads of life and death, Nat. Immunol., 3, 221, 10.1038/ni0302-221 Bonizzi, 2004, The two NF-kappaB activation pathways and their role in innate and adaptive immunity, Trends Immunol., 25, 280, 10.1016/j.it.2004.03.008 Hayden, 2004, Signaling to NF-kappaB, Genes Dev., 18, 2195, 10.1101/gad.1228704 Zang, 2013, Inhibition of pan-class I PI3 kinase by NVP-BKM120 effectively blocks proliferation and induces cell death in diffuse large B cell lymphoma, Leuk. Lymphoma, 55, 425, 10.3109/10428194.2013.806800 Reeder, 2011, Novel therapeutic agents for B-cell lymphoma: developing rational combinations, Blood, 117, 1453, 10.1182/blood-2010-06-255067